STIM Logo

Neuronetics, Inc. (STIM) 

NASDAQ
Market Cap
$35.76M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
155 of 776
Rank in Industry
8 of 42

Largest Insider Buys in Sector

STIM Stock Price History Chart

STIM Stock Performance

About Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of …

Insider Activity of Neuronetics, Inc.

Over the last 12 months, insiders at Neuronetics, Inc. have bought $362,788 and sold $828,099 worth of Neuronetics, Inc. stock.

On average, over the past 5 years, insiders at Neuronetics, Inc. have bought $497,417 and sold $2.35M worth of stock each year.

Highest buying activity among insiders over the last 12 months: CASCELLA ROBERT (director) — $832,980. MUIR GLENN P (director) — $170,257.

The last purchase of 100,000 shares for transaction amount of $75,000 was made by CASCELLA ROBERT (director) on 2024‑09‑12.

List of Insider Buy and Sell Transactions, Neuronetics, Inc.

2024-10-08SaleEVP, CFO and Treasurer
1,368
0.0047%
$0.82$1,122+9.93%
2024-10-08SaleEVP, GC, CCO and CS
1,541
0.0053%
$0.82$1,264+9.93%
2024-09-12Purchasedirector
100,000
0.3345%
$0.75$75,000+22.97%
2024-09-05Purchasedirector
25,000
0.0843%
$0.80$20,000+13.65%
2024-08-29Purchasedirector
12,224
0.0404%
$0.85$10,390+3.54%
2024-08-28Purchasedirector
12,776
0.0408%
$0.85$10,860-0.65%
2024-08-20Purchasedirector
25,000
0.0809%
$1.00$25,000-13.08%
2024-08-19Purchasedirector
4,000
0.0149%
$1.14$4,560-11.88%
2024-08-16Purchasedirector
35,000
0.165%
$1.06$37,100-4.72%
2024-08-15Purchasedirector
35,000
0.137%
$0.88$30,8000.00%
2024-08-14Purchasedirector
35,000
0.123%
$0.79$27,6500.00%
2024-08-14Purchasedirector
25,171
0.084%
$0.75$18,8780.00%
2024-07-18SalePresident and CEO
24,162
0.0805%
$1.90$45,908-51.58%
2024-07-17SalePresident and CEO
11,687
0.0384%
$1.97$23,023-53.76%
2024-07-16SalePresident and CEO
12,075
0.0444%
$1.91$23,063-53.52%
2024-06-06Purchasedirector
50,000
0.1684%
$2.05$102,550-52.00%
2024-02-29SaleEVP, GC, CCO and CS
6,026
0.0207%
$2.94$17,716-35.67%
2024-02-28SaleEVP, CFO and Treasurer
3,985
0.0147%
$3.16$12,593-33.84%
2024-02-28SaleEVP, GC, CCO and CS
22,377
0.0827%
$3.16$70,711-33.84%
2024-02-27SaleEVP, CFO and Treasurer
21,272
0.0756%
$3.33$70,836-38.46%

Insider Historical Profitability

16.91%
Furlong StephenEVP, CFO and Treasurer
497408
1.6412%
$1.18224+50.62%
CASCELLA ROBERTdirector
453098
1.495%
$1.1890<0.0001%
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
402792
1.329%
$1.18125+123.41%
MUIR GLENN Pdirector
289818
0.9563%
$1.1860<0.0001%
CANNELL CAPITAL LLC10 percent owner
3127819
10.3203%
$1.181817+18.48%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Archon Capital Management Llc$12.08M8.462.54M0%+$00.27
Cannell Capital LLC$11.73M8.212.46M-11.05%-$1.46M2.76
Divisadero Street Capital Management Lp$7.33M5.131.54MNew+$7.33M1.72
The Vanguard Group$6.19M4.331.3M-3.93%-$253,370.07<0.0001
Silvercrest Asset Management Group Inc$5.61M3.931.18M+4.61%+$246,953.540.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.